Rare diseases
Investigational molecules
Locations
Back to Belgium34 clinical trials in Alken, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2
BelgiumStudy of trospium chloride and xanomeline tartrate (KarXT) in patients with psychosis associated with Alzheimer's disease
BelgiumStudy on Long-Term Safety of KarXT (Trospium Chloride, Xanomeline Tartrate) for Patients with Alzheimer's-Related Psychosis
BelgiumSARS‑CoV‑2 spike protein vaccine and drug combination study in adults 60 years and older with COVID‑19 and influenza
BelgiumA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
BelgiumStudy on TAK-861 for Treating Narcolepsy with Cataplexy in Patients
BelgiumStudy on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections
BelgiumWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
BelgiumA study to evaluate the efficacy and safety of zenagamtide in people with obesity
BelgiumStudy of ALKS 2680 to treat excessive daytime sleepiness in people with idiopathic hypersomnia
BelgiumStudy on COVID-19 Prevention Using Sipavibart and Cilgavimab for Patients with Weakened Immune Systems
BelgiumStudy on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Research focusing on respiratory syncytial virus (RSV) in older adults and chronic sinus conditions, evaluating novel therapeutic approaches for respiratory health.
Investigating immune responses and testing new treatments for nasal congestion and polyp reduction.
Comprehensive studies examining treatments for narcolepsy and sleep disturbances, with particular focus on different narcolepsy types and menopausal sleep issues.
Testing innovative compounds to improve excessive daytime sleepiness and related symptoms.
Advanced research into major depressive disorder and Alzheimer's-related conditions, exploring new therapeutic approaches for complex neuropsychiatric symptoms.
Evaluating novel treatments and combination therapies for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
